Beverly Hills Cancer Center /ID# 255327 — Beverly Hills, California

Beverly Hills Cancer Center /ID# 255327 is a clinical research site located in Beverly Hills, California, United States 90211.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Beverly Hills Cancer Center /ID# 255327 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Diffuse Large B-Cell Lymphoma, Classic Follicular Lymphoma.

Sponsors: Genmab.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Beverly Hills Cancer Center /ID# 255327?

Beverly Hills Cancer Center /ID# 255327 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Beverly Hills Cancer Center /ID# 255327 conducted?

Beverly Hills Cancer Center /ID# 255327 has 1 clinical trials on record, with 1 currently active. Their work covers Diffuse Large B-Cell Lymphoma, Classic Follicular Lymphoma.

Is Beverly Hills Cancer Center /ID# 255327 accredited by Crixeo Health?

Beverly Hills Cancer Center /ID# 255327 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Beverly Hills Cancer Center /ID# 255327?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.